Key facts
- Notable investors include University of Toronto, Merck Digital Sciences Studio, Ontario Centre of Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Orb Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Orb Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orb Therapeutics
Operator of a biotechnology company intended to develop RNA-based therapies to treat a range of genetic diseases. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2023
- Website
- orbtx.co/
- Ownership
- Privately Held (backing)
Orb Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orb Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orb Therapeutics in its N-PORT filings yet. We sweep new filings monthly.